Skip to content

Neurospectrum Insights Corp.

Country not established

Devices
1

What Neurospectrum Insights Corp. makes

Neurospectrum Insights Corp. develops the GyriCalc, a software tool designed to analyze and quantify cortical gyri patterns in neuroimaging data, aiding in neurological assessments and research.

The company’s portfolio is regulated under FDA Class II devices and is listed in the 510(k) premarket notification registry. The company is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • GyriCalc (Version 1.0.0) Ref K250686

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Neurospectrum Insights Corp. have in the registry?

The registry currently lists 1 device for Neurospectrum Insights Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Neurospectrum Insights Corp.'s devices?

Among its 1 most recently registered device, Neurospectrum Insights Corp. has devices listed in FDA 510(k) (1 device).

What risk classes do Neurospectrum Insights Corp.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Neurospectrum Insights Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Neurospectrum Insights Corp. in the registry?

The most recently registered devices listed for Neurospectrum Insights Corp. include GyriCalc (Version 1.0.0).

Generated automatically from registry data and not verified by a human reviewer.